HPGC Renmintongtai Pharmaceutical Corp Cash Flow Quality Index
HPGC Renmintongtai Pharmaceutical Corp cash flow quality index. HPGC Renmintongtai Pharmaceutical Corp (600829) has a Cash Flow Quality Index of -4.77x as of September 2025. Operating cash flow of CN¥-187.38 Million is below net income of CN¥39.30 Million, suggesting accrual-heavy earnings not yet converted to cash. See financial flexibility index of HPGC Renmintongtai Pharmaceutical Corp to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of HPGC Renmintongtai Pharmaceutical Corp (1998–2025)
Cash flow quality index of HPGC Renmintongtai Pharmaceutical Corp from 1998 to 2025. Historical Cash Flow Quality Index for HPGC Renmintongtai Pharmaceutical Corp across 27 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore HPGC Renmintongtai Pharmaceutical Corp (600829) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
HPGC Renmintongtai Pharmaceutical Corp Cash Flow Quality Index by Year (1998–2025)
HPGC Renmintongtai Pharmaceutical Corp cash flow quality index by year from 1998 to 2025. Year-by-year earnings quality comparison for HPGC Renmintongtai Pharmaceutical Corp. For the full cash flow conversion analysis, see cash flow conversion of HPGC Renmintongtai Pharmaceutical Corp.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.24x | CN¥299.98 Million | CN¥133.84 Million | ▲ +314.1% |
| 2024 | 0.54x | CN¥115.44 Million | CN¥213.27 Million | ▼ -52.5% |
| 2023 | 1.14x | CN¥332.99 Million | CN¥292.16 Million | ▼ -2.3% |
| 2022 | 1.17x | CN¥307.33 Million | CN¥263.41 Million | ▲ +238.5% |
| 2021 | -0.84x | CN¥-233.00 Million | CN¥276.51 Million | ▼ -1224.5% |
| 2020 | -0.06x | CN¥-9.22 Million | CN¥144.96 Million | ▲ +95.9% |
| 2019 | -1.54x | CN¥-411.60 Million | CN¥267.30 Million | ▼ -208.4% |
| 2018 | 1.42x | CN¥366.45 Million | CN¥257.85 Million | ▲ +159.8% |
| 2017 | 0.55x | CN¥139.07 Million | CN¥254.20 Million | ▲ +167.0% |
| 2016 | 0.20x | CN¥46.01 Million | CN¥224.51 Million | ▼ -91.9% |
| 2015 | 2.52x | CN¥333.99 Million | CN¥132.54 Million | ▼ -83.2% |
| 2014 | 14.97x | CN¥392.58 Million | CN¥26.23 Million | ▲ +2287.9% |
| 2012 | 0.63x | CN¥221.57 Million | CN¥353.49 Million | ▲ +324.8% |
| 2011 | -0.28x | CN¥-108.30 Million | CN¥388.48 Million | ▼ -158.0% |
| 2010 | 0.48x | CN¥162.99 Million | CN¥339.38 Million | ▼ -68.5% |
| 2009 | 1.53x | CN¥447.82 Million | CN¥293.52 Million | ▲ +749.5% |
| 2008 | -0.23x | CN¥-65.93 Million | CN¥280.68 Million | ▼ -133.4% |
| 2007 | 0.70x | CN¥191.10 Million | CN¥271.83 Million | ▼ -20.8% |
| 2006 | 0.89x | CN¥191.13 Million | CN¥215.32 Million | ▼ -43.3% |
| 2005 | 1.57x | CN¥313.04 Million | CN¥199.80 Million | ▲ +4.8% |
| 2004 | 1.50x | CN¥60.69 Million | CN¥40.59 Million | ▼ -62.9% |
| 2003 | 4.03x | CN¥71.65 Million | CN¥17.79 Million | ▼ -68.1% |
| 2002 | 12.61x | CN¥127.49 Million | CN¥10.11 Million | ▲ +3668.1% |
| 2001 | 0.33x | CN¥14.79 Million | CN¥44.21 Million | ▼ -66.7% |
| 2000 | 1.01x | CN¥61.85 Million | CN¥61.54 Million | ▼ -96.0% |
| 1999 | 25.06x | CN¥58.21 Million | CN¥2.32 Million | ▼ -52.3% |
| 1998 | 52.50x | CN¥41.00 Million | CN¥780.86K | — |